Literature DB >> 9169608

Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly.

M A Utton1, A Vandecandelaere, U Wagner, C H Reynolds, G M Gibb, C C Miller, P M Bayley, B H Anderton.   

Abstract

To study the effects of phosphorylation by glycogen synthase kinase-3beta (GSK-3beta) on the ability of the microtubule-associated protein tau to promote microtubule self-assembly, tau isoform 1 (foetal tau) and three mutant forms of this tau isoform were investigated. The three mutant forms of tau had the following serine residues, known to be phosphorylated by GSK-3, replaced with alanine residues so as to preclude their phosphorylation: (1) Ser-199 and Ser-202 (Ser-199/202-->Ala), (2) Ser-235 (Ser-235-->Ala) and (3) Ser-396 and Ser-404 (Ser-396/404-->Ala). Wild-type tau and the mutant forms of tau were phosphorylated with GSK-3beta, and their ability to promote microtubule self-assembly was compared with the corresponding non-phosphorylated tau species. In the non-phosphorylated form, wild-type tau and all of the mutants affected the mean microtubule length and number concentrations of assembled microtubules in a manner consistant with enhanced microtubule nucleation. Phosphorylation of these tau species with GSK-3beta consistently reduced the ability of a given tau species to promote microtubule self-assembly, although the affinity of the tau for the microtubules was not greatly affected by phosphorylation since the tau species remained largely associated with the microtubules. This suggests that the regulation of microtubule assembly can be controlled by phosphorylation of tau at sites accessible to GSK-3beta by a mechanism that does not necessarily involve the dissociation of tau from the microtubules.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169608      PMCID: PMC1218378          DOI: 10.1042/bj3230741

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  52 in total

1.  The balance between tau protein's microtubule growth and nucleation activities: implications for the formation of axonal microtubules.

Authors:  R Brandt; G Lee
Journal:  J Neurochem       Date:  1993-09       Impact factor: 5.372

2.  Inhibition of microtubule nucleation at the neuronal centrosome compromises axon growth.

Authors:  F J Ahmad; H C Joshi; V E Centonze; P W Baas
Journal:  Neuron       Date:  1994-02       Impact factor: 17.173

3.  Effects of the tubulin-colchicine complex on microtubule dynamic instability.

Authors:  A Vandecandelaere; S R Martin; M J Schilstra; P M Bayley
Journal:  Biochemistry       Date:  1994-03-15       Impact factor: 3.162

4.  PHF-tau from Alzheimer's brain comprises four species on SDS-PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase-3 beta.

Authors:  S F Mulot; K Hughes; J R Woodgett; B H Anderton; D P Hanger
Journal:  FEBS Lett       Date:  1994-08-08       Impact factor: 4.124

5.  Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.

Authors:  S Lovestone; C H Reynolds; D Latimer; D R Davis; B H Anderton; J M Gallo; D Hanger; S Mulot; B Marquardt; S Stabel
Journal:  Curr Biol       Date:  1994-12-01       Impact factor: 10.834

6.  Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262.

Authors:  G Drewes; B Trinczek; S Illenberger; J Biernat; G Schmitt-Ulms; H E Meyer; E M Mandelkow; E Mandelkow
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

7.  Microtubule-stabilizing activity of microtubule-associated proteins (MAPs) is due to increase in frequency of rescue in dynamic instability: shortening length decreases with binding of MAPs onto microtubules.

Authors:  T J Itoh; H Hotani
Journal:  Cell Struct Funct       Date:  1994-10       Impact factor: 2.212

8.  Proline-directed and non-proline-directed phosphorylation of PHF-tau.

Authors:  M Morishima-Kawashima; M Hasegawa; K Takio; M Suzuki; H Yoshida; K Titani; Y Ihara
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

9.  Stimulation of MAP kinase by v-raf transformation of fibroblasts fails to induce hyperphosphorylation of transfected tau.

Authors:  D A Latimer; J M Gallo; S Lovestone; C C Miller; C H Reynolds; B Marquardt; S Stabel; J R Woodgett; B H Anderton
Journal:  FEBS Lett       Date:  1995-05-22       Impact factor: 4.124

10.  Tau protein kinase I/GSK-3 beta/kinase FA in heparin phosphorylates tau on Ser199, Thr231, Ser235, Ser262, Ser369, and Ser400 sites phosphorylated in Alzheimer disease brain.

Authors:  J S Song; S D Yang
Journal:  J Protein Chem       Date:  1995-02
View more
  23 in total

Review 1.  Tau as a therapeutic target for Alzheimer's disease.

Authors:  A Boutajangout; E M Sigurdsson; P K Krishnamurthy
Journal:  Curr Alzheimer Res       Date:  2011-09       Impact factor: 3.498

Review 2.  Changes in the ageing brain in health and disease.

Authors:  B H Anderton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-12-29       Impact factor: 6.237

Review 3.  Tau-induced neurodegeneration: mechanisms and targets.

Authors:  Cindy Beharry; Leah S Cohen; Jing Di; Kawsar Ibrahim; Susan Briffa-Mirabella; Alejandra del C Alonso
Journal:  Neurosci Bull       Date:  2014-04-15       Impact factor: 5.203

Review 4.  Disrupting self-assembly and toxicity of amyloidogenic protein oligomers by "molecular tweezers" - from the test tube to animal models.

Authors:  Aida Attar; Gal Bitan
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

5.  Alzheimer's Disease and Protein Kinases.

Authors:  Ayse Basak Engin; Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Brain-Defective Insulin Signaling Is Associated to Late Cognitive Impairment in Post-Septic Mice.

Authors:  Fernanda S Neves; Patrícia T Marques; Fernanda Barros-Aragão; José Bruno Nunes; Aline M Venancio; Danielle Cozachenco; Rudimar L Frozza; Giselle F Passos; Robson Costa; Jade de Oliveira; Daiane F Engel; Andreza F De Bem; Claudia F Benjamim; Fernanda G De Felice; Sergio T Ferreira; Julia R Clarke; Claudia P Figueiredo
Journal:  Mol Neurobiol       Date:  2016-12-13       Impact factor: 5.590

Review 7.  Tau function and dysfunction in neurons: its role in neurodegenerative disorders.

Authors:  Jesús Avila; Filip Lim; Francisco Moreno; Carlos Belmonte; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

Review 8.  The rise and fall of insulin signaling in Alzheimer's disease.

Authors:  B Chami; A J Steel; S M De La Monte; Greg T Sutherland
Journal:  Metab Brain Dis       Date:  2016-02-16       Impact factor: 3.584

9.  Tau phosphorylation and cleavage in ethanol-induced neurodegeneration in the developing mouse brain.

Authors:  Mariko Saito; Goutam Chakraborty; Rui-Fen Mao; Sun-Mee Paik; Csaba Vadasz; Mitsuo Saito
Journal:  Neurochem Res       Date:  2010-01-05       Impact factor: 3.996

10.  Transient phosphorylation of tumor associated microtubule associated protein (TMAP)/cytoskeleton associated protein 2 (CKAP2) at Thr-596 during early phases of mitosis.

Authors:  Kyung Uk Hong; Yong-Bock Choi; Jung-Hwa Lee; Hyun-Jun Kim; Hye-Rim Kwon; Yeon-Sun Seong; Heung Tae Kim; Joobae Park; Chang-Dae Bae; Kyeong-Man Hong
Journal:  Exp Mol Med       Date:  2008-08-31       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.